Transave, Inc.
Transave is a biotechnology company whose mission is to improve the treatment of serious lung diseases through the company's next generation, proprietary liposomal delivery technology providing prolonged release of a drug in the lung while minimizing systemic exposure. Transave is currently developing new therapies which may improve the therapeutic index for treating lung infections that have a pseudomonas component, such as cystic fibrosis and bronchiectasis via inhalation directly to the site of the disease.

Back to list.